- Home
- AKAN vs SPRC Comparison
AKAN vs SPRC Comparison
Compare AKAN & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKAN
- SPRC
- Stock Information
- Founded
- AKAN 2021
- SPRC 2004
- Country
- AKAN Canada
- SPRC Israel
- Employees
- AKAN N/A
- SPRC N/A
- Industry
- AKAN Medicinal Chemicals and Botanical Products
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- AKAN Health Care
- SPRC Health Care
- Exchange
- AKAN Nasdaq
- SPRC Nasdaq
- Market Cap
- AKAN 2.9M
- SPRC 3.0M
- IPO Year
- AKAN 2022
- SPRC N/A
- Fundamental
- Price
- AKAN $1.34
- SPRC $4.54
- Analyst Decision
- AKAN
- SPRC
- Analyst Count
- AKAN 0
- SPRC 0
- Target Price
- AKAN N/A
- SPRC N/A
- AVG Volume (30 Days)
- AKAN 562.6K
- SPRC 37.0K
- Earning Date
- AKAN 08-26-2025
- SPRC 01-01-0001
- Dividend Yield
- AKAN N/A
- SPRC N/A
- EPS Growth
- AKAN N/A
- SPRC N/A
- EPS
- AKAN N/A
- SPRC N/A
- Revenue
- AKAN $836,664.00
- SPRC $1,306,000.00
- Revenue This Year
- AKAN N/A
- SPRC N/A
- Revenue Next Year
- AKAN N/A
- SPRC N/A
- P/E Ratio
- AKAN N/A
- SPRC N/A
- Revenue Growth
- AKAN 97.47
- SPRC N/A
- 52 Week Low
- AKAN $0.93
- SPRC $4.00
- 52 Week High
- AKAN $2.90
- SPRC $37.59
- Technical
- Relative Strength Index (RSI)
- AKAN 54.15
- SPRC 28.06
- Support Level
- AKAN $1.00
- SPRC $5.05
- Resistance Level
- AKAN $1.43
- SPRC $5.65
- Average True Range (ATR)
- AKAN 0.17
- SPRC 0.49
- MACD
- AKAN 0.02
- SPRC -0.15
- Stochastic Oscillator
- AKAN 47.22
- SPRC 21.05
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.